Alzheimer’s Society Comment on Today’s ‘Breakthrough’ Alzheimer’s Drug
Dr Richard Oakley, Associate Director of Research at Alzheimer’s Society, comments on news surrounding breakthrough Alzheimer’s drug lecanemab. Today’s (November 30) exciting results offer our…
Read more...